Vimarsana
Biggest News Aggregation in the World

Michael Pehl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Pehl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Pehl Today - Breaking & Trending Today

Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline - Vimarsana News

Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline

Raises additional 16M EUR led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors.Funds will be used to further strengthen growing pipeline of first in

Adcendo Raises €16M; Extends Series A to €98M - Vimarsana News

Adcendo Raises €16M; Extends Series A to €98M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Adcendo Appoints Experienced Drug Developer Dr. Lone H. Ottesen as Chief Medical Officer - Vimarsana News

Adcendo Appoints Experienced Drug Developer Dr. Lone H. Ottesen as Chief Medical Officer

/PRNewswire/ -- Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of...

Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-Class ADC Pipeline - Vimarsana News

Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-Class ADC Pipeline

/PRNewswire/ -- Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of...

Adcendo expands partnership with Duality Biologics - Vimarsana News

Adcendo expands partnership with Duality Biologics

Adcendo has expanded its partnership with fellow biotech company Duality Biologics, in an effort to "broaden and expand" the collaboration.